bf/NASDAQ:FENC_icon.jpeg

NASDAQ:FENC

Fennec Pharmaceuticals Inc.

  • Stock

USD

Last Close

11.09

28/03 20:00

Market Cap

263.68M

Beta: 0.16

Volume Today

117.93K

Avg: 80.91K

PE Ratio

−11.72

PFCF: −16.43

  • industry

    Biotechnology
  • exchange

    NASDAQ Capital Market
  • website

    www.fennecpharma.com
  • ipo date

    Jun 05, 2001
  • full time employees

    36
  • currency

    USD

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex T...Show More

Earnings per Share (Estimate*)

12342015-11-122017-08-112019-08-092021-05-132023-03-27

Revenue (Estimate*)

5M10M15M20M25M30M35M2015-11-122017-08-112019-08-092021-05-132023-03-27

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.